Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Alx Oncology Holdings Inc (NASDAQ: ALXO) was $8.13 for the day, up 1.63% from the previous closing price of $8.00. In other words, the price has increased by $1.63 from its previous closing price. On the day, 1.05 million shares were traded. ALXO stock price reached its highest trading level at $8.78 during the session, while it also had its lowest trading level at $7.83.
Ratios:
Our analysis of ALXO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.21 and its Current Ratio is at 5.21. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on March 08, 2024, Downgraded its rating to Hold and sets its target price to $14 from $10 previously.
On December 08, 2023, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $8 to $18.
Jefferies Downgraded its Buy to Hold on December 22, 2021, whereas the target price for the stock was revised from $65 to $25.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 11 ’24 when Pons Jaume sold 20,000 shares for $7.90 per share. The transaction valued at 158,076 led to the insider holds 593,447 shares of the business.
Pinto Shelly sold 1,823 shares of ALXO for $10,025 on Jul 05 ’24. The SVP, FINANCE AND CAO now owns 92,113 shares after completing the transaction at $5.50 per share. On Jul 01 ’24, another insider, Pons Jaume, who serves as the PRESIDENT & CSO of the company, sold 10,758 shares for $5.82 each. As a result, the insider received 62,599 and left with 593,447 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALXO now has a Market Capitalization of 423573824 and an Enterprise Value of 282978880.
Stock Price History:
The Beta on a monthly basis for ALXO is 1.11, which has changed by 0.14265633 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, ALXO has reached a high of $17.83, while it has fallen to a 52-week low of $3.94. The 50-Day Moving Average of the stock is -21.01%, while the 200-Day Moving Average is calculated to be -29.55%.
Shares Statistics:
ALXO traded an average of 868.68K shares per day over the past three months and 970890 shares per day over the past ten days. A total of 49.95M shares are outstanding, with a floating share count of 29.79M. Insiders hold about 42.83% of the company’s shares, while institutions hold 56.38% stake in the company. Shares short for ALXO as of 1719532800 were 5511962 with a Short Ratio of 6.35, compared to 1717113600 on 2912170. Therefore, it implies a Short% of Shares Outstanding of 5511962 and a Short% of Float of 18.5.
